New
HealthMore in Health →
Blood-Based RNA Biomarkers Could Open a New Path for Detecting Inflammatory Breast Cancer
Researchers say a broader RNA sequencing approach has identified blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes, potentially enabling less invasive diagnosis and monitoring
Key Takeaways
- Researchers identified blood-based genomic biomarkers for inflammatory breast cancer.
- The study used TGIRT sequencing to capture a broader RNA profile.
DE
DT Editorial AI··via medicalxpress.com